Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-07-02Clinical Trial Update: The Antidepressant Effect of Repetitive Transcranial Magnetic Stimulation (rTMS)Compared to ECT [Phase 2, Phase 3]
This document reports the completion of Phase 2 and Phase 3 trials comparing repetitive transcranial magnetic stimulation (rTMS) with electr…
-
FDA approval · 2008-07-02FDA Approved: CITALOPRAM — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for the generic antidepressant citalopram, authorizing Chartwell Governmental & Specialty RX, LLC to…
-
FDA approval · 2008-06-25FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for sertraline hydrochloride manufactured by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS research · 2008-06-24Clinical Trial Update: Development of a Web-Based Interactive Patient Decision Aid for the Treatment of Acute Low Back Pain and Depression [NA]
The document reports the completion of a clinical trial focused on developing a web-based interactive decision aid to help patients and clin…
-
CLINICAL_TRIALS trial_result · 2008-06-18Clinical Trial Update: Evaluation of Impacts of Access to Credit and Loan Size for Microcredit Clients in South Africa [NA]
A completed clinical trial evaluating how access to credit and loan size affect mental health outcomes among microcredit clients in South Af…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-06-13FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited as an original application for a generic antidepressant product…
-
FDA approval · 2008-06-13FDA Approved: VENLAFAXINE — Original Application (BluePoint Laboratories)
FDA approved an original application for venlafaxine from BluePoint Laboratories (venlafaxine hydrochloride) under an Abbreviated New Drug A…
-
CLINICAL_TRIALS trial_result · 2008-06-13Clinical Trial Update: Zinc Supplementation of Imipramine Therapy [NA]
A completed clinical trial evaluating zinc supplementation in combination with imipramine for major depressive disorder.
-
FDA approval · 2008-06-13FDA Approved: VENLAFAXINE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's generic venlafaxine under an original ANDA (ANDA078627). The approval adds a generic option for treating m…
-
CLINICAL_TRIALS trial_result · 2008-06-04Clinical Trial Update: Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine [Phase 4]
Phase 4 clinical trial evaluating duloxetine for major depressive episodes occurring during psychotic disorders has completed, assessing its…
-
CLINICAL_TRIALS trial_result · 2008-06-04Clinical Trial Update: Antidepressant Maintenance in Traumatic Brain Injury [Phase 4]
Phase 4 clinical trial update on maintenance antidepressant therapy in patients with depression following traumatic brain injury.
-
CLINICAL_TRIALS research · 2008-06-04Clinical Trial Update: PEARL Intervention to Reduce Depression Among Adults With Epilepsy [NA]
This ClinicalTrials.gov entry reports on the PEARL intervention to reduce depression in adults with epilepsy; the study status is unknown an…
-
FDA approval · 2008-06-03FDA Approved: MIRTAZAPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for mirtazapine from Sun Pharmaceutical Industries, indicating regulatory clearance related to a gen…
-
FDA approval · 2008-05-29FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for a generic fluoxetine hydrochloride product from Lannett Company, Inc. under anANDA, confirming r…
-
CLINICAL_TRIALS research · 2008-05-29Clinical Trial Update: A Trial of Two On-Line Interventions for Child Brain Injury [NA]
Completed clinical trial evaluating two online interventions for children with traumatic brain injury and co-occurring depression or anxiety…
-
CLINICAL_TRIALS trial_result · 2008-05-28Clinical Trial Update: Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression [Phase 4]
A Phase 4 study evaluating whether quantitative EEG markers can predict treatment outcomes in major depressive disorder has completed.
-
FDA approval · 2008-05-23FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2008-05-21FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for SEROQUEL XR (quetiapine) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2008-05-20FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride/paroxetine from Zydus Lifesciences Limited, authorizing a generic parox…
-
CLINICAL_TRIALS research · 2008-05-20Clinical Trial Update: The Neurobiology of Depressive Illness [NA]
An update on a Baker Heart Research Institute clinical trial studying the neurobiology of depressive illness in individuals with major depre…
-
FDA approval · 2008-05-20FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Vertical Pharmaceuticals, LLC)
The FDA approved a generic venlafaxine hydrochloride product (Original Application) developed by Vertical Pharmaceuticals, LLC, for the trea…
-
CLINICAL_TRIALS trial_result · 2008-05-19Clinical Trial Update: Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression [NA]
A completed clinical trial (NCT00285727) evaluating ropinirole controlled-release as an adjunctive treatment for major depressive disorder h…
-
CLINICAL_TRIALS trial_result · 2008-05-19Clinical Trial Update: St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid Anxiety [Phase 2]
This document notes the completion of a Phase 2 clinical trial evaluating St. John's Wort and Kava for major depressive disorder with comorb…
-
CLINICAL_TRIALS trial_result · 2008-04-30Clinical Trial Update: Clinical and Cost Effectiveness of Brief Cognitive-Behavioral Therapy (CBT) for Pediatric Internalizing Disorders [Phase 2]
This Phase 2 trial evaluated the clinical and cost effectiveness of a brief cognitive-behavioral therapy program for pediatric depression an…
-
FDA approval · 2008-04-23FDA Approved: APLENZIN — Original Application (Bausch Health US, LLC)
FDA approved APLENZIN (bupropion hydrobromide) through an original application for the treatment of major depressive disorder.